[Vasopressin V2-receptor antagonist, tolvaptan, for treatment of heart failure].
Yamamura
Yoshitaka
Y
Department of Clinical Research and Development, Otsuka Pharmaceutical Co., Ltd.
Sato
Osamu
O
Fujiki
Hiroyuki
H
D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines / Q000494:pharmacology / Q000627:therapeutic use*; D001826:Body Fluids / Q000378:metabolism; D002986:Clinical Trials as Topic; D004231:Diuresis / Q000187:drug effects; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007010:Hyponatremia / Q000150:complications / Q000188:drug therapy; D000077602:Tolvaptan
D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines; D000077602:Tolvaptan